Innovative stem cell therapy shows promise in restoring insulin production for severe type 1 diabetes patients.

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

Generally speaking, when someone has Type 1 diabetes, their blood contains a marker – called islet autoantibodies – that ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in ...

Researchers at the University of Michigan found that mitochondria also accumulate misfolded proteins, which kills β-cells.

Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

A small clinical trial has shown that lab-grown cells, known as zimislecel, can restore insulin production in people with severe type 1 diabetes.